Takeda Pharmaceutical Co Ltd (NYSE:TAK)

Delayed Data
As of Dec 08
 -0.02 / -0.14%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 16.30, with a high estimate of 19.38 and a low estimate of 13.70. The median estimate represents a +15.95% increase from the last price of 14.06.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Hold stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 251.19%
Growthannually -43.64%


Growthquarterly 5.14%
Growthannually -6.21%
Key to the earnings and sales forecast charts.